A5100678119- Bipolar Disorder and Treatment
- Schizophrenia research and treatment
- Treatment of Major Depression
- Tryptophan and brain disorders
- Mental Health Research Topics
- Neurotransmitter Receptor Influence on Behavior
- Genetic Associations and Epidemiology
- Genetics and Neurodevelopmental Disorders
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Child and Adolescent Psychosocial and Emotional Development
- Electroconvulsive Therapy Studies
- Pharmacogenetics and Drug Metabolism
- Autism Spectrum Disorder Research
- Receptor Mechanisms and Signaling
- Diet and metabolism studies
- Functional Brain Connectivity Studies
- Attention Deficit Hyperactivity Disorder
- Alzheimer's disease research and treatments
- Obsessive-Compulsive Spectrum Disorders
- Sirtuins and Resveratrol in Medicine
- Phosphodiesterase function and regulation
- Personality Disorders and Psychopathology
- Genetic Syndromes and Imprinting
- Neuroendocrine regulation and behavior
- Cholinesterase and Neurodegenerative Diseases
University of Bologna
2014-2023
Centre Hospitalier Universitaire de Nîmes
2023
University of Milano-Bicocca
2023
Medico
2023
Universität Innsbruck
2020-2021
Ospedale di Bolzano
2020-2021
Innsbruck Medical University
2020-2021
Fujita Health University
2016
Clinica Universidad de Navarra
2016
Northwestern University
2016
REVIEW article Front. Pharmacol., 16 February 2011Sec. Pharmacogenetics and Pharmacogenomics volume 2 - 2011 | https://doi.org/10.3389/fphar.2011.00006
This European multicenter study aimed to elucidate suicidality in major depressive disorder. Previous surveys suggest a prevalence of disorder ≥50%, but little is known about the association different degrees with socio-demographic, psychosocial, and clinical characteristics.We stratified 1410 patients into 3 categories based on Hamilton Rating Scale for Depression item (suicidality) ratings (0=no suicidality; 1-2=mild/moderate 3-4=severe suicidality). Chi-squared tests, analyses covariance,...
<i>Aim:</i> The present study aimed to explore whether some single nucleotide polymorphisms (SNPs) within the <i>BDNF</i> gene could be associated with major depression (MD), bipolar disorder (BD) and schizophrenia, they predict clinical outcomes in Korean inpatients treated antidepressants, mood stabilizers antipsychotics, respectively. <i>Methods:</i> One hundred forty-five patients MD, 132 BD, 221 schizophrenia 170 psychiatrically healthy controls were...
Objective This multicenter, multinational, cross‐sectional study aimed to investigate clinical characteristics and treatment outcomes associated with augmentation/combination strategies in major depressive disorder ( MDD ). Method Sociodemographic, clinical, features of 1410 adult patients were compared between treated monotherapy medication using descriptive statistics, analyses covariance ancova ), Spearman's correlation analyses. Results 60.64% all participants received augmentation...
To elucidate the impact of presence psychotic features in patients diagnosed with major depressive disorder (MDD) on sociodemographic, psychosocial, clinical, and response characteristics.A total 1,410 DSM-IV-TR MDD were included present European multicenter study, which was conducted between 2011 2016. Analyses covariance, χ² tests, binary logistic regression analyses performed to explore differences sociodemographic clinical variables without symptoms.A prevalence rate 10.92% for found...
Introduction: Social dysfunction is a common symptom of several neuropsychiatric disorders. However, only in the last few years research began to systematically investigate clinical aspects this relevant outcome. Interestingly, its distribution and link with other variables still unclear. This study investigated social 4 different cohorts patients affected by mood disorders schizophrenia evaluate 1) degree these populations; 2) associations among socio-demographic psychopathological...